The network analysis revealed a positive link between ERBB2 and PPP3CB, which suggested that PPP3CB might inhibit pancreatic cancer through the ERBB pathway, because the ERBB family are overexpressed in pancreatic cancer and play key roles in its carcinogenesis [36]. The gene discussed is ERBB2; the disease is familial pancreatic carcinoma.